One-Year Safety Analysis of the COMPARE-AMI Trial: Comparison of Intracoronary Injection of CD133(+) Bone Marrow Stem Cells to Placebo in Patients after Acute Myocardial Infarction and Left Ventricular Dysfunction

Bone marrow stem cell therapy has emerged as a promising approach to improve healing of the infarcted myocardium. Despite initial excitement, recent clinical trials using non-homogenous stem cells preparations showed variable and mixed results. Selected CD133(+) hematopoietic stem cells are candidat...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Mansour, Samer, Roy, Denis-Claude, Bouchard, Vincent, Stevens, Louis Mathieu, Gobeil, Francois, Rivard, Alain, Leclerc, Guy, Reeves, François, Noiseux, Nicolas
Formato: Artigo
Lenguaje:Inglês
Publicado: Hindawi Publishing Corporation 2011
Materias:
Clinical Study
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3200002/
https://ncbi.nlm.nih.gov/pubmed/22046562
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2011/385124
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares